Ortoma receives FDA 510 (k) clearance for OTS™ Hip in the US
Ortoma AB (publ), a trailblazer in the realm of orthopedic technology, announces that it has obtained FDA 510(k)...
Ortoma to Showcase Revolutionary Solution for Converting X-ray images to 3D models at ISTA Congress ahead of Market Release scheduled in 2024
Ortoma AB (publ), a trailblazer in the realm of orthopedic technology, is set to make a groundbreaking impact at...
Ortoma announces agreement to provide AI-based solution for total hip arthroplasty
Ortoma AB, a Swedish medical technology company, has announced that it has signed a development and distribution...
Ortoma to present groundbreaking 2D-3D technology for knee and hip joints at the annual ISTA congress in New York 2023
Ortoma AB (publ), a pioneer in the field of orthopedic technology, announces that two abstracts have been accepted...
Ortoma’s OTS™ Hip is launched in Japan
Following a clinical evaluation of Ortoma’s OTS™ Hip solution, Ortoma is now working with Johnson & Johnson...
Ortoma presents an advanced prototype for its new 3D concept in conjunction with AAOS in Las Vegas, March 7th – March 10th, 2023
Ortoma AB (publ) will be at the American Academy of Orthopedic Surgeons, AAOS event in Las Vegas, March 7-10, 2023....
Ortoma agrees on term sheet for development and distribution of customized version of OTS Hip
Ortoma AB (publ) (”Ortoma” or the ”Company”) has agreed on a non-binding term sheet with the DePuy Synthes family...
Strong interest in Ortoma’s new 3D modelling concept
Ortoma AB (publ) (”Ortoma” or the ”Company”) today announces that the Company's proof-of-concept presentations of...
Ortoma completes training session for surgeons ahead of pilot period in Japan
Ortoma AB (publ) (”Ortoma” or the ”Company”) has recently hosted a successful training session for leading Japanese...